• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JCI Insight . Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus

tetano

Editor, Senior Moderator
JCI Insight


. 2021 Apr 22;146082.
doi: 10.1172/jci.insight.146082. Online ahead of print.
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus


Ami Patel[SUP] 1 [/SUP], Emma L Reuschel[SUP] 1 [/SUP], Ziyang Xu[SUP] 1 [/SUP], Faraz I Zaidi[SUP] 1 [/SUP], Kevin Y Kim[SUP] 1 [/SUP], Dana P Scott[SUP] 2 [/SUP], Janess Mendoza[SUP] 3 [/SUP], Stephanie Ramos[SUP] 3 [/SUP], Regina Stoltz[SUP] 1 [/SUP], Friederike Feldmann[SUP] 2 [/SUP], Atsushi Okumura[SUP] 4 [/SUP], Kimberly Meade-White[SUP] 4 [/SUP], Elaine Haddock[SUP] 4 [/SUP], Tina Thomas[SUP] 5 [/SUP], Rebecca Rosenke[SUP] 5 [/SUP], Jamie Lovaglio[SUP] 5 [/SUP], Patrick W Hanley[SUP] 5 [/SUP], Greg Saturday[SUP] 5 [/SUP], Kar Muthumani[SUP] 1 [/SUP], Heinz Feldmann[SUP] 4 [/SUP], Laurent M Humeau[SUP] 3 [/SUP], Kate E Broderick[SUP] 3 [/SUP], David B Weiner[SUP] 1 [/SUP]



Affiliations

Abstract

Emerging coronaviruses from zoonotic reservoirs including severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been associated with human-to-human transmission and significant morbidity and mortality. Here we study both intradermal (ID) and intramuscular (IM) two-dose delivery regimens of an advanced synthetic DNA vaccine candidate encoding a full-length MERS-CoV Spike (S) protein, which induced potent binding and neutralizing antibodies, as well as cellular immune responses in rhesus macaques. In a MERS-CoV challenge, all immunized rhesus macaques exhibited reduced clinical symptoms, lowered viral lung load, and decreased severity of pathological signs of disease compared to controls. ID vaccination was dose sparing and more effective in this model at protecting animals from disease. The data support the further study of this vaccine for preventing MERS-CoV infection and transmission, including investigation of such vaccines and simplified delivery routes against emerging coronaviruses.

Keywords: Adaptive immunity; Infectious disease; Vaccines.
 
Back
Top Bottom